image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Lords

March 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • LORD
  • Price:
  • 82p
After a period in the doldrums, the shares have rallied after Lords said trading is ahead of market expectations for 2022. Revenues grew 24% to £450m with Merchanting sales up 69.2%, helped by value-added acquisitions and market share gains; like-for-like sales growth was 17.4%. New EBITDA guidance is for 26.9% growth to no less than £28.3m with ebitda margin +0.2% to 6.3% despite the inflationary backdrop for costs and “underlines the operational discipline of the business.”  The group closed with net debt of £23.5m.  Cenkos says Lords’ IPO target to hit £500m revenues by FY’24 is well on track with “a number of organic growth levers through new geographies and product range extensions while its market share in fragmented ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author